Fol. Biol. 2018, 64, 97-102
https://doi.org/10.14712/fb2018064030097
Serum Levels of Aryl Hydrocarbon Receptor, Cytochromes P450 1A1 and 1B1 in Patients with Exacerbated Psoriasis Vulgaris
References
1. , G., Krüger-Krasagakis, S., Krasagakis, K., Fragiadaki, I., Kokolakis, G., Tosca, A. (2010) The role of endothelial cell apoptosis in the effect of etanercept in psoriasis. Br. J. Dermatol. 163, 928-934.
<https://doi.org/10.1111/j.1365-2133.2010.09935.x>
2. , J. M., Höller, D., Schiffer, R., Frankenberg, S., Neis, M., Merk, H. F., Jugert, F. K. (2001) Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J. Invest. Dermatol. 116, 541-548.
<https://doi.org/10.1046/j.1523-1747.2001.01298.x>
3. , M., Fiala, Z., Kremlacek, J., Andrys, C., Hamakova, K., Chmelarova, M., Palicka, V., Borska, L. (2016) Genetic polymorphisms in biotransformation enzymes for benzo[a] pyrene and related levels of benzo[a]pyrene-7,8-diol-9,10- epoxide-DNA adducts in Goeckerman therapy. Toxicol. Lett. 255, 47-51.
<https://doi.org/10.1016/j.toxlet.2016.05.009>
4. , M., Fiala, Z., Kremlacek, J., Andrys, C., Krejsek, J., Hamakova, K., Chmelarova, M., Palicka, V., Borska, L. (2017) Changes in circulating cell-free DNA and nucleosomes in patients with exacerbated psoriasis. Arch. Dermatol. Res. 309, 815-821.
<https://doi.org/10.1007/s00403-017-1785-5>
5. , C., Mussi, A., Carducci, M., Pittarello, A., D’Auria, L., Venuti, A., Bagnato, A., Salani, D., Fazio, M., Ameglio, F. (1998) Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm. Venereol. 78, 22-26.
<https://doi.org/10.1080/00015559850135779>
6. , S., Oliveira, H., Reis, F., Belo, L., Rocha, S., Quintanilha, A., Figueiredo, A., Teixeira, F., Castro, E., Rocha- Pereira, P., Santos-Silva, A. (2010) Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J. Eur. Acad. Dermatol. Venereol. 24, 1386-1394.
<https://doi.org/10.1111/j.1468-3083.2010.03647.x>
7. , M. (2014) AHR: making the keratinocytes thick skinned. Immunity 40, 863-864.
<https://doi.org/10.1016/j.immuni.2014.06.001>
8. , M. S., Nagy S. R. (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334.
<https://doi.org/10.1146/annurev.pharmtox.43.100901.135828>
9. , M,, Bhutani, T., Koo, J., Liao, W. (2013) Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy. J. Dermatolog. Treat. 24, 2-6.
<https://doi.org/10.3109/09546634.2011.607794>
10. , C., Kaina, B. (2010) The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis 31, 1319-1328.
<https://doi.org/10.1093/carcin/bgq028>
11. , P., Duarte, J. H., Ahlfors, H., Owens, N. D., Li, Y., Villanova, F., Tosi, I., Hirota, K., Nestle, F. O., Mrowietz, U., Gilchrist, M. J., Stockinger, B. (2014) Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity 40, 989-1001.
<https://doi.org/10.1016/j.immuni.2014.04.019>
12. , N. H., Kadry, D., Hegazy, R. A., Rashed, L. (2013) Estimation of tissue osteopontin levels before and after different traditional therapeutic modalities in psoriatic patients. J. Eur. Acad. Dermatol. Venereol. 27, 351-355.
<https://doi.org/10.1111/j.1468-3083.2011.04417.x>
13. , C., Bargen, I., Weighardt, H., Haarmann-Stemmann, T., Krutmann, J. (2013) Functions of the aryl hydrocarbon receptor in the skin. Semin. Immunopathol. 35, 677-691.
<https://doi.org/10.1007/s00281-013-0394-4>
14. , A., Rossi, G. A., Bagnasco, M., De Flora, S. (1991) Benzo[a]pyrene diolepoxide-DNA adducts in alveolar macrophages of smokers. Carcinogenesis 12, 1281-1285.
<https://doi.org/10.1093/carcin/12.7.1281>
15. , A., Liapi, C., Katoulis, A., Stavropoulos, P., Avgerinou, G., Georgala, S., Economopoulos, T., Stavrianeas, N. G., Katsambas, A. (2011) The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept. Clin. Exp. Dermatol. 36, 845-850.
<https://doi.org/10.1111/j.1365-2230.2011.04131.x>
16. , A. S., Uzunçakmak, T. K., Ozkanli, S., Oguztuzun, S., Moran, B., Akbulak, O., Ozlu, E., Zemheri, I. E., Bilgili, S. G., Akdeniz, N. (2017) An investigation of cytochrome p450 (CYP) and glutathione S-transferase (GST) isoenzyme protein expression and related interactions with phototherapy in patients with psoriasis vulgaris. Int. J. Dermatol. 56, 225-231.
<https://doi.org/10.1111/ijd.13343>
17. , S. K., Matsui, M. S., Mukhtar, H. (2000) Ultraviolet- B exposure of human skin induces cytochromes P450 1A1 and 1B1. J. Invest. Dermatol. 114, 328-333.
<https://doi.org/10.1046/j.1523-1747.2000.00876.x>
18. , H. O., Kim, J. H., Chung, B. Y., Choi, M. G., Park, C. W. (2014) Increased expression of the aryl hydrocarbon receptor in patients with chronic inflammatory skin diseases. Exp. Dermatol. 23, 278-281.
<https://doi.org/10.1111/exd.12350>
19. , S., Stroisch, T. J., Vorac, J., Herrmann, N., Leib, N., Schnautz, S., Kirins, H., Förster, I., Weighardt, H., Bieber, T. (2017) AhR mediates an anti-inflammatory feedback mechanism in human Langerhans cells involving FcεRI and IDO. Allergy 72, 1686-1693.
<https://doi.org/10.1111/all.13170>
20. , K., Borska, L., Andrys, C., Krejsek, J., Hamakova, K., Rendarova, S., Rehacek, V., Kremlacek, J., Fiala, Z. (2015) Selected inflammatory and metabolic markers in psoriatic patients treated with Goeckerman therapy. Mediators Inflamm. 2015, 979526.
<https://doi.org/10.1155/2015/979526>
21. , S., Sinha, N., Gerth, K. A., Rahman, M. A., Yallapu, M. M., Midde, N. M. (2017) Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications. Biochem. Biophys. Res. Commun. 491, 675-680.
<https://doi.org/10.1016/j.bbrc.2017.07.145>
22. , M. G., Bachelez, H., Barker, J., Girolomoni, G., Kavanaugh, A., Langley, R. G., Paul, C. F., Puig, L., Reich, K., van de Kerkhof, P. C. (2014) Patient perspectives in the management of psoriasis: results from the populationbased Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J. Am. Acad. Dermatol. 70, 871-881.
<https://doi.org/10.1016/j.jaad.2013.12.018>
23. , R. J., Schultz, J. E., Boehncke, W. H., Podda, M., Tandi, C., Krombach, F., Baatz, H., Kaufmann, R., von Andrian, U. H., Zollner, T. M. (2004) Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J. Invest. Dermatol. 122, 830-836.
<https://doi.org/10.1111/j.0022-202X.2004.22318.x>
24. , D. W., Dalton, T. P., Okey, A. B., Gonzalez, F. J. (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279, 23847-23850.
<https://doi.org/10.1074/jbc.R400004200>
25. , C. T. H., Kambe, N., Yamazaki, F., Ueda-Hayakawa, I., Kishimoto, I., Okamoto, H. (2018) Up-regulated expression of CD86 on circulating intermediate monocytes correlated with disease severity in psoriasis. J. Dermatol. Sci. 90, 135-143.
<https://doi.org/10.1016/j.jdermsci.2018.01.005>
26. , L. P., Bradfield, C. A. (2008) The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 21, 102-116.
<https://doi.org/10.1021/tx7001965>
27. , N. T., Hanieh, H., Nakahama, T., Kishimoto, T. (2013) The roles of aryl hydrocarbon receptor in immune responses. Int. Immunol. 25, 335-343.
<https://doi.org/10.1093/intimm/dxt011>
28. , G., Baki, A. M., Yorulmaz, E., Doğru-Abbasoğlu, S., Vural, P. (2016) Serum visfatin, fetuin-A, and pentraxin 3 levels in patients with psoriasis and their relation to disease severity. J. Clin. Lab. Anal. 30, 284-289.
<https://doi.org/10.1002/jcla.21850>
29. , R., Philipp, S., Höflich, C., Kreutzer, S., Wallace, E., Asadullah, K., Volk, H. D., Sterry, W., Wolk, K. (2007) Immunopathogenesis of psoriasis. Exp. Dermatol. 16, 779-798.
<https://doi.org/10.1111/j.1600-0625.2007.00629.x>
30. , R. M., Perera, F. P., Young, T. L., Zhang, Y. J., Chiamprasert, S., Tang, D., Wang, L. W., Beachman, A., Lin, J. H., DeLeo, V. A. (1995) Polycyclic aromatic hydrocarbon- DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype. Mutat. Res. 334, 117-124.
<https://doi.org/10.1016/0165-1161(95)90001-2>
31. , P., Britschgi, M., Keller, M., Steiner, U. C., Steinmann, L. S., Moser, B., Pichler, W. J. (2004) Characterization of human T cells that regulate neutrophilic skin inflammation. J. Immunol. 173, 2151-2158.
<https://doi.org/10.4049/jimmunol.173.3.2151>
32. , S., Jeon, C., Nakamura, M., Afifi, L., Yan, D., Wu, J., Liao, W., Bhutani, T. (2017) Review of the mechanism of action of coal tar in psoriasis. J. Dermatolog. Treat. 2017, 1-3.
33. , A. B., Sokolowska, M., Chodynicka, B. (2007) Tumour necrosis factor α (TNF-α)-converting enzyme (TACE) and soluble TNF-α receptor type 1 in psoriasis patients treated with narrowband ultraviolet B. Photodermatol. Photoimmunol. Photomed. 23, 130-134.
<https://doi.org/10.1111/j.1600-0781.2007.00296.x>
34. , L. K., Bunde, K. L., Harper, T. A. Jr, McQuistan, T. J., Löhr, C. V., Bramer, L.M., Waters, K. M., Tilton, S. C., Krueger, S. K., Williams, D. E., Baird, W. M. (2015) Cytochrome P450 1b1 in polycyclic aromatic hydrocarbon (PAH)-induced skin carcinogenesis: Tumorigenicity of individual PAHs and coal-tar extract, DNA adduction and expression of select genes in the Cyp1b1 knockout mouse. Toxicol. Appl. Pharmacol. 287, 149-160.
<https://doi.org/10.1016/j.taap.2015.05.019>
35. , B. W., Stanford, E. A., Sherr, D. H., Murphy, G. J. (2016) Genome editing of the CYP1A1 locus in iPSCs as a platform to Map AhR expression throughout human development. Stem Cells Int. 2016, 2574152.
<https://doi.org/10.1155/2016/2574152>
36. , B., Di Meglio, P., Gialitakis, M., Duarte, J. H. (2014) The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 32, 403-432.
<https://doi.org/10.1146/annurev-immunol-032713-120245>
